Terms: = Leukemia AND NCOA4, RP11-481A12_4, 8031, ENSG00000138293, PTC3, ELE1, Q13772, RFG, DKFZp762E1112, ARA70 AND Staging
245 results:
1. Impact of Binet staging versus Tumour Bulk on Treatment Outcome in Chronic Lymphocytic Leukaemia.
Madu AJ; Okoye HC; Muoghalu EA; Ugwu AO; Duru AN; Nonyelu CE; Anigbogu IO; Ezekekwu CA
Niger Postgrad Med J; 2024 Jan; 31(1):76-80. PubMed ID: 38321800
[TBL] [Abstract] [Full Text] [Related]
2. Factors affecting survival in stage 2-3 colorectal cancer: a single-center retrospective study.
Karahan M; Mulkut F; Okut G
Eur Rev Med Pharmacol Sci; 2024 Jan; 28(2):615-621. PubMed ID: 38305605
[TBL] [Abstract] [Full Text] [Related]
3. Secondary Analysis of the Rate of Second Primary Lung Cancer From Cancer and leukemia Group B 140503 (Alliance) Trial of Lobar Versus Sublobar Resection for T1aN0 Non-Small-Cell Lung Cancer.
Stinchcombe TE; Wang X; Damman B; Mentlick J; Landreneau R; Wigle D; Jones DR; Conti M; Ashrafi AS; Liberman M; de Perrot M; Mitchell JD; Keenan R; Bauer T; Miller D; Altorki N
J Clin Oncol; 2024 Apr; 42(10):1110-1113. PubMed ID: 38215351
[No Abstract] [Full Text] [Related]
4. [Effect of Circulating Plasma Cells on the Prognosis of Patients with Multiple Myeloma].
Li F; Gao YJ; Li SS; Xi YY; Yang XW; Su YH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1771-1779. PubMed ID: 38071059
[TBL] [Abstract] [Full Text] [Related]
5. [Efficacy and safety of TBI+rATG-based conditioning regimen for haploidentical allogeneic hematopoietic stem cell transplantation in 11 cases of chemotherapy-resistant advanced peripheral T-cell lymphoma].
Xu R; Li S; Liu HX; Wei DL; Jiang Y; Wang JJ; Liu SS; Wang C; Zhu J
Zhonghua Xue Ye Xue Za Zhi; 2023 Jul; 44(7):578-581. PubMed ID: 37749039
[No Abstract] [Full Text] [Related]
6. Characteristics and outcome of infectious complications after autologous hematopoietic cell transplantation in multiple myeloma patients.
Jandial A; Lad D; Jain A; Khadwal A; Singh C; Prakash G; Suri V; Sreedharanunni S; Sachdeva MUS; Ray P; Varma N; Varma S; Malhotra P
Transpl Infect Dis; 2023 Oct; 25(5):e14123. PubMed ID: 37573150
[TBL] [Abstract] [Full Text] [Related]
7. Myeloid/Lymphoid Neoplasm with FGFR1 Rearrangement Presenting with Polycythemia Vera and T-cell Acute Lymphoblastic leukemia.
Marinelli LM; Romain JT; Ehman W; Ortega V; Velagaleti G; Gibbons TF; Nazario-Toole A; Holmes AR
Cancer Genet; 2023 Aug; 276-277():43-47. PubMed ID: 37480761
[TBL] [Abstract] [Full Text] [Related]
8. Clinical Characteristics and Outcomes of Cancer Cases Among Syrian Refugees From Southern Turkey.
Kutluk T; Sahin B; Kirazli M; Ahmed F; Aydin S; Yesil Çinkir H; Sezgin G; Bayram I; Ebinç S; Isikdogan A; Sasmaz I; Okan V; Ilhan G; Ören AC; Akbayram S; Harputluoglu H; Ural C; Ayyildiz O; Aktas G; Uçar MA; Güvenç B; Köse D; Acipayam C; Güncan S; Erçolak V; Berber I; Akdeniz A; Akyay A; Üzel VH; Söker M; Sengelen M; Yalçin S; Sullivan R
JAMA Netw Open; 2023 May; 6(5):e2312903. PubMed ID: 37219908
[TBL] [Abstract] [Full Text] [Related]
9. Role of social status and social environment on net survival in patients with chronic lymphocytic leukemia: A high-resolution population-based study.
Delapierre B; Troussard X; Damaj G; Dejardin O; Tron L
Cancer Epidemiol; 2023 Feb; 82():102292. PubMed ID: 36410088
[TBL] [Abstract] [Full Text] [Related]
10. [Mid-term efficacy of China Net Childhood Lymphoma-mature B-cell lymphoma 2017 regimen in the treatment of pediatric Burkitt lymphoma].
Zhang M; Wu P; Duan YL; Jin L; Yang J; Huang S; Liu Y; Hu B; Zhai XW; Wang HS; Fu Y; Li F; Yang XM; Liu AS; Qin S; Yuan XJ; Dong YS; Liu W; Zhou JW; Zhang LP; Jia YP; Wang J; Qu LJ; Dai YP; Guan GT; Sun LR; Jiang J; Liu R; Jin RM; Wang ZJ; Wang XG; Zhang BX; Chen KL; Zhuang SQ; Zhang J; Zhou CJ; Gao ZF; Zheng MC; Zhang Y
Zhonghua Er Ke Za Zhi; 2022 Oct; 60(10):1011-1018. PubMed ID: 36207847
[No Abstract] [Full Text] [Related]
11. Immune status does not independently influence cutaneous squamous cell carcinoma metastasis and death when stratified by tumor stage: A dual-center retrospective cohort analysis of primary N0 disease.
O'Connor DM; Murad F; Danesh MJ; Butler W; Smile TD; Ilori EO; Gastman BR; Vidimos A; Waldman AB; Schmults CD; Koyfman S; Ruiz ES
J Am Acad Dermatol; 2022 Dec; 87(6):1295-1302. PubMed ID: 36063987
[TBL] [Abstract] [Full Text] [Related]
12. Detection of a second primary cancer in a 18F-fluorocholine PET/CT - multicentre retrospective analysis on a group of 1345 prostate cancer patients.
Cegla P; Scibisz-Dziedzic K; Witkowska K; Kubiak A; Wierzchoslawska E; Kycler W; Chrapko B; Czepczyński R
Nucl Med Rev Cent East Eur; 2022; 25(1):25-30. PubMed ID: 35137934
[TBL] [Abstract] [Full Text] [Related]
13. Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN): a randomised, head-to-head, open-label, phase 3 study.
Schjesvold FH; Dimopoulos MA; Delimpasi S; Robak P; Coriu D; Legiec W; Pour L; Špička I; Masszi T; Doronin V; Minarik J; Salogub G; Alekseeva Y; Lazzaro A; Maisnar V; Mikala G; Rosiñol L; Liberati AM; Symeonidis A; Moody V; Thuresson M; Byrne C; Harmenberg J; Bakker NA; Hájek R; Mateos MV; Richardson PG; Sonneveld P;
Lancet Haematol; 2022 Feb; 9(2):e98-e110. PubMed ID: 35032434
[TBL] [Abstract] [Full Text] [Related]
14. Outcomes of children and young adults with T-cell acute lymphoblastic leukemia/lymphoma who present in critical status.
Wayne NJ; Li Y; Chung P; Coffan K; Rheingold SR
Pediatr Blood Cancer; 2022 Apr; 69(4):e29457. PubMed ID: 34997812
[TBL] [Abstract] [Full Text] [Related]
15. Level of Scientific Evidence Underlying the National Comprehensive Cancer Network Clinical Practice Guidelines for Hematologic Malignancies: Are We Moving Forward?
Chengappa M; Desai A; Go R; Poonacha T
Oncology (Williston Park); 2021 Jul; 35(7):390-396. PubMed ID: 34270186
[TBL] [Abstract] [Full Text] [Related]
16. How to Treat High-Risk Myeloma at Diagnosis and Relapse.
Caro J; Al Hadidi S; Usmani S; Yee AJ; Raje N; Davies FE
Am Soc Clin Oncol Educ Book; 2021 Mar; 41():291-309. PubMed ID: 34010042
[TBL] [Abstract] [Full Text] [Related]
17. Unusual clinical scenarios in Urology and Andrology.
Dell'Atti L; Fabiani A; Palagonia E; Edoardo A; Pavia MP; Scarcella S; Maurelli V; Principi E; Tiroli M; Milanese G; Servi L; Galosi AB
Arch Ital Urol Androl; 2021 Mar; 93(1):120-126. PubMed ID: 33754624
[TBL] [Abstract] [Full Text] [Related]
18. Bortezomib, lenalidomide, and dexamethasone with or without elotuzumab in patients with untreated, high-risk multiple myeloma (SWOG-1211): primary analysis of a randomised, phase 2 trial.
Usmani SZ; Hoering A; Ailawadhi S; Sexton R; Lipe B; Hita SF; Valent J; Rosenzweig M; Zonder JA; Dhodapkar M; Callander N; Zimmerman T; Voorhees PM; Durie B; Rajkumar SV; Richardson PG; Orlowski RZ;
Lancet Haematol; 2021 Jan; 8(1):e45-e54. PubMed ID: 33357482
[TBL] [Abstract] [Full Text] [Related]
19. [Fluorescence in Situ Hybridization for Detecting Molecular Cytogenetic Abnormalities of Chronic Lymphocytic leukemia].
Zhang HY; Yang YL; Zhao Q; Zhang J; Bai H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1474-1479. PubMed ID: 33067940
[TBL] [Abstract] [Full Text] [Related]
20. Increasing incidence of cancer and stage migration towards advanced disease in children and young adolescents in the Netherlands, 1990-2017.
Reedijk AMJ; Kremer LC; Visser O; Lemmens V; Pieters R; Coebergh JWW; Karim-Kos HE
Eur J Cancer; 2020 Jul; 134():115-126. PubMed ID: 32521425
[TBL] [Abstract] [Full Text] [Related]
[Next]
